when was semaglutide patented Off-patent in 2026: the next revolution in anti-obesity medications China patent expiry and new

In humans, the concern is focused on medullary thyroid carcinoma, which is rare and biologically distinct from the more common papillary and follicular thyroid cancers

The informal designation "GLP-3" used in the research community is not an official receptor nomenclature but rather a shorthand reflecting retatrutide's position as the third generation of GLP-class metabolic peptides

Frequent Monitoring Pregnancy requires more intensive diabetes monitoring than you might be used to

JJ Androgenic alopecia, or male pattern baldness, is typically related to genetics and aging

Vielhaber S, Kaufmann J, et al

The Bottom Line on L-Carnitine L-carnitine is a worthwhile supplement, but not for the reasons that many people claim